Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
North America Non-Fusion Technologies Market North America Non-Fusion Technologies Market
The North American Non-Fusion Technologies market has seen challenging and dynamic market conditions. The North American Spinal Fusion & Fixation market, mainly driven by aging population and the increasing prevalence of rheumatoid and osteoarthritis.Some of the key players in The North American Non-Fusion Technologies market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
Asia Vertebral Compression Fracture Treatment Market Asia Vertebral Compression Fracture Treatment Market
The report “The Asian Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices. Some of the key players in The Asian Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
Europe Vertebral Compression Fracture Treatment Market Europe Vertebral Compression Fracture Treatment Market
The report “The European Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices.Some of the key players in The European Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
North America Vertebral Compression Fracture Treatment Market North America Vertebral Compression Fracture Treatment Market
The report “The North American Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices.Some of the key players in The North American Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
North American Pulmonary drug delivery devices Market North American Pulmonary drug delivery devices Market
The North American Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $13.8 billion in 2013 and expected to be $24 billion by 2018, growing at a CAGR of 11.8%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
European Pulmonary drug delivery devices Market European Pulmonary drug delivery devices Market
The European Pulmonary Drug Delivery devices devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $7.5 billion in 2013 and expected to be $12.4billion by 2018, growing at a CAGR of 10.6%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
Asian Pulmonary Drug Delivery devices Market Asian Pulmonary Drug Delivery devices Market
The Asian Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $7.7 billion by 2018, growing at a CAGR of 16.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
North American Radiology PACS Market North American Radiology PACS Market
The North American radiology PACS market was valued at $898.8 million in 2013, and is expected to grow at a CAGR of 3.1% from 2014 to 2019.  This market is segmented on the basis of geography, application, deployment, and end-user. Deep dive analysis of the top market players have also been considered in this report.
Upcoming
European Radiology PACS European Radiology PACS
The European radiology picture archiving and communication system (PACS) market was valued at $513.6million in 2013, and is expected to grow at a CAGR of 4.3% from 2014 to 2019. This market is segmented on the basis of geography, application, deployment, and end-user. Deep dive analysis of the top market players have also been considered in this report.
Upcoming
Asian Radiology PACS Market Asian Radiology PACS Market
The Asian radiology picture archiving and communication system (PACS) market was valued at $275.4 million in 2013, which is expected to grow at a CAGR of 5.5% from 2014 to 2019. This market has been segmented on the basis of geography, application, deployment, and end-user. A DeepDive analysis of the top market players has also been considered in this report.
Upcoming
North American Active Transdermal Drug Delivery Devices Market North American Active Transdermal Drug Delivery Devices Market
The North American Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $712 million in 2013 and expected to be $1339 million by 2018, growing at a CAGR of 13.5 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Enterprise Picture Archiving and Communication System (PACS) Enterprise Picture Archiving and Communication System (PACS)
The global enterprise picture archiving and communication system (PACS) market was valued at $300.0 million in 2013, and is expected to grow at a CAGR of 10.4% from 2014-2019.. This market is segmented on the basis of geography, application, deployment, and end-user. Deep dive analysis of the top market players have also been considered in this report.  
Upcoming
European Active Transdermal Drug Delivery Devices Market European Active Transdermal Drug Delivery Devices Market
The European Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $353 million in 2013 and expected to be $633 million by 2018, growing at a CAGR of 12.4 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Active Transdermal Drug Delivery Devices Market Asian Active Transdermal Drug Delivery Devices Market
The Asian Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $109 million in 2013 and expected to be $188 million by 2018, growing at a CAGR of 11.6 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Enterprise Picture Archiving and Communication System (PACS) North American Enterprise Picture Archiving and Communication System (PACS)
The market for enterprise PACS in North America is segmented on the basis of types, deployment, component, key applications, end-users, and geography. The market is estimated to witness a CAGR of 9.5% between 2014 and 2019.
Upcoming
European Enterprise Picture Archiving and Communication System (PACS) European Enterprise Picture Archiving and Communication System (PACS)
The market segmentation in this report is done in various segments, such as on the basis of types, deployment, component, key applications and end-users, and by geography (major countries of the region). The European Enterprise PACS Market is estimated to register a CAGR of 10.8% between 2014 and 2019.
Upcoming
Asian Enterprise Picture Archiving and Communication System (PACS) Asian Enterprise Picture Archiving and Communication System (PACS)
The Asian Enterprise Picture Archiving and Communication System (PACS) market was valued at $40 million in 2012, and is projected to reach $78 million by 2018, at a CAGR of 12.0%. This market is segmented on the basis of geography, application, deployment, and end-users. Deep dive analysis of the key market players, along with recent financials, product portfolio, and growth strategies are also considered in this report. 
Upcoming
North American Passive Transdermal Drug Delivery Market North American Passive Transdermal Drug Delivery Market
The North American Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $6.85 billion in 2013 and expected to be $11.33 billion by 2018, growing at a CAGR of 10.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Passive Transdermal Drug Delivery Market European Passive Transdermal Drug Delivery Market
The European Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $3.27 billion in 2013 and expected to be $5.19 billion by 2018, growing at a CAGR of 9.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Passive Transdermal Drug Delivery Market Asian Passive Transdermal Drug Delivery Market
The Asian Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $1.40 billion in 2013 and expected to be $2.82 billion by 2018, growing at a CAGR of 15.0%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539